The journey is as important as the destination

The Advanced Therapy Supply Chain is complex and made up of multiple moving parts. Watch this engaging webinar to hear real-world case studies that illustrate the challenges the sector is currently facing and discuss the approaches required to enable advanced therapy developers to build robust, commercial-scale, supply chains that enable patients to benefit from these life-changing therapies.

Hear from two leading experts – Simon Ellison and Kristen Franklin, Fisher BioServices – discussing the:

• Unique challenges that may be encountered when planning your logistics strategy for an allogeneic or autologous therapy.
• Importance of centralized control and communication throughout the supply chain.
• Potential impact of early planning on risk mitigation and cost of goods in clinical supply chain management.

Following the presentations, is a Q&A session including questions from our audience.

By registering to view this On Demand Webinar you are also signing up as a member of Cell & Gene Therapy Insights and agree to be contacted by Cell & Gene Therapy Insights’ sponsors. We will email you a username and password so you can read all our open access content.

Simon Ellison

Senior Manager, Advanced Therapies at

Simon is the Senior Manager, Advanced Therapies at Fisher BioServices. With the aim of building a supply chain solution that addresses the industries challenge of operations at commercial scale. Whilst at the Cell and Gene Therapy Catapult Simon identified the need for, and built the Seamless Freight portfolio. He also helped develop the commercial operating model for the Catapult Manufacturing Centre that resulted in the first collaborators entering, and the start of a cluster forming around this unique facility.
Prior to this Simon was the Head of Commercial at NHS Blood and Transplant (NHSBT) where he merged the needs of the industry with NHSBTs manufacturing capability. This enabled multiple UK and International organisations to move their therapies forwards.

Kristen Franklin

Client Services Manager, Cell Therapy at Thermo Fisher Scientific

Kristen is the Client Services Manager for Cell Therapy projects at Fisher BioServices. In her current role, Kristen manages a team of Project Managers who interact with clients to provide logistic and strategic support for cell therapy clinical trials, as well as commercialization operations. Kristen’s background is in process development and manufacturing of biologics, as well as project management. She holds a Master’s degree from the University of Maryland in Biotechnology Management.

Watch now

SPEAKERS

Simon Ellison

Senior Manager, Advanced Therapies at

Kristen Franklin

Client Services Manager, Cell Therapy at Thermo Fisher Scientific

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 64

Days

Register

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko

6 June

in 43

Days

Register

Advancing cell therapy: innovations in polymer-based encapsulation and delivery

B Yevgeniy, O Veiseh, M Delic-Schlumbohm et al.

5 June

in 42

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 35

Days

Register

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz

23 May

in 29

Days

Register